These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment. Hoopes P; Strawbridge R; Gibson U; Zeng Q; Pierce Z; Savellano M; Tate J; Ogden J; Baker I; Ivkov R; Foreman A Proc SPIE Int Soc Opt Eng; 2007 Feb; 6440():64400K. PubMed ID: 25301985 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Breast Cancer-Bearing BALB/c Mice with Magnetic Hyperthermia using Dendrimer Functionalized Iron-Oxide Nanoparticles. Salimi M; Sarkar S; Hashemi M; Saber R Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33266461 [TBL] [Abstract][Full Text] [Related]
6. Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease. Zadnik PL; Molina CA; Sarabia-Estrada R; Groves ML; Wabler M; Mihalic J; McCarthy EF; Gokaslan ZL; Ivkov R; Sciubba D J Neurosurg Spine; 2014 Jun; 20(6):740-50. PubMed ID: 24702509 [TBL] [Abstract][Full Text] [Related]
7. Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer. Stocke NA; Sethi P; Jyoti A; Chan R; Arnold SM; Hilt JZ; Upreti M Biomaterials; 2017 Mar; 120():115-125. PubMed ID: 28056401 [TBL] [Abstract][Full Text] [Related]
8. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer. Li FR; Yan WH; Guo YH; Qi H; Zhou HX Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033 [TBL] [Abstract][Full Text] [Related]
9. Toxicity and Biodistribution of Activated and Non-activated Intravenous Iron Oxide Nanoparticles. Tate J; Ogden J; Strawbridge R; Pierce Z; Hoopes P Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810L. PubMed ID: 25300674 [TBL] [Abstract][Full Text] [Related]
10. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer. Oei AL; Korangath P; Mulka K; Helenius M; Coulter JB; Stewart J; Velarde E; Crezee J; Simons B; Stalpers LJA; Kok HP; Gabrielson K; Franken NAP; Ivkov R Int J Hyperthermia; 2019 Nov; 36(sup1):47-63. PubMed ID: 31795835 [No Abstract] [Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
12. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration. Aboushoushah S; Alshammari W; Darwesh R; Elbaily N Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288 [TBL] [Abstract][Full Text] [Related]
13. Triple Therapy of HER2 Zolata H; Afarideh H; Davani FA Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759 [TBL] [Abstract][Full Text] [Related]
14. Systemically Delivered Magnetic Hyperthermia for Prostate Cancer Treatment. Albarqi HA; Demessie AA; Sabei FY; Moses AS; Hansen MN; Dhagat P; Taratula OR; Taratula O Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33113767 [TBL] [Abstract][Full Text] [Related]
15. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050 [TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Hayashi K; Nakamura M; Sakamoto W; Yogo T; Miki H; Ozaki S; Abe M; Matsumoto T; Ishimura K Theranostics; 2013; 3(6):366-76. PubMed ID: 23781284 [TBL] [Abstract][Full Text] [Related]
18. Optimization Study on Specific Loss Power in Superparamagnetic Hyperthermia with Magnetite Nanoparticles for High Efficiency in Alternative Cancer Therapy. Caizer C Nanomaterials (Basel); 2020 Dec; 11(1):. PubMed ID: 33375292 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model. Tate JA; Kett W; NDong C; Griswold KE; Hoopes PJ Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840G. PubMed ID: 25301995 [TBL] [Abstract][Full Text] [Related]
20. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. Balivada S; Rachakatla RS; Wang H; Samarakoon TN; Dani RK; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL BMC Cancer; 2010 Mar; 10():119. PubMed ID: 20350328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]